Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited) - USD ($)	AST Lease Amendment [Member] Common Stock [Member]	AST Lease Amendment [Member] Additional Paid-in Capital [Member]	AST Lease Amendment [Member] Retained Earnings [Member]	AST Lease Amendment [Member] Noncontrolling Interest [Member]	AST Lease Amendment [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Noncontrolling Interest [Member]	Total
BALANCE (in shares) at Dec. 31, 2024						23,507,577
BALANCE at Dec. 31, 2024						$ 156,590	$ 395,263,560	$ (335,651,065)	$ 0	$ 59,769,085
Common stock issuance costs						$ 0	(145,000)	0	0	(145,000)
Issuance of common stock for debt issuance costs (in shares)						110,059
Issuance of common stock for debt issuance costs						$ 733	531,182	0	0	531,915
Issuance of common stock for conversion of debt and accrued interest (in shares)						1,490,624
Issuance of common stock for conversion of debt and accrued interest						$ 1,798	3,999,445	0	0	4,001,243
Issuance of common stock in lieu of payment of interest (in shares)						35,366
Issuance of common stock in lieu of payment of interest						$ 117	142,305	0	0	142,422
Adjustment for fractional shares in connection with reverse split (in shares)						246
Issuance of common stock for lease amendment (in shares)	985,000
Issuance of common stock for lease amendment	$ 656	$ 2,481,544	$ 0	$ 0	$ 2,482,200
Issuance of common stock for LINICO acquisition-related payable (in shares)						775,000
Issuance of common stock for LINICO acquisition-related payable						$ 516	1,859,484	0	0	1,860,000
Net loss						$ 0	0	(9,093,931)	0	$ (9,093,931)
Issuance of common stock for cash (in shares)										1,839,390
BALANCE (in shares) at Mar. 31, 2025						26,903,872
BALANCE at Mar. 31, 2025						$ 160,410	404,132,520	(344,744,996)	0	$ 59,547,934
BALANCE (in shares) at Dec. 31, 2024						23,507,577
BALANCE at Dec. 31, 2024						$ 156,590	395,263,560	(335,651,065)	0	59,769,085
BALANCE (in shares) at Dec. 31, 2025						51,853,490
BALANCE at Dec. 31, 2025						$ 177,026	486,130,452	(378,727,508)	3,321,020	110,900,990
Common stock issuance costs						0	(4,606,575)	0	0	(4,606,575)
Net loss						$ 0	0	(9,383,417)	0	(9,383,417)
Issuance of common stock for cash (in shares)						21,781,929
Issuance of common stock for cash						$ 14,507	60,964,674	0	0	60,979,181
Issuance of common stock for director compensation (in shares)						463,721
Issuance of common stock for director compensation						$ 309	1,863,850	0	0	1,864,159
BALANCE (in shares) at Mar. 31, 2026						74,099,140
BALANCE at Mar. 31, 2026						$ 191,842	$ 544,352,401	$ (388,110,925)	$ 3,321,020	$ 159,754,338